Primers used for PCR and qRTPCR. by Huan W. Yang (19746645)

“…<i>intracellularis</i> infection. In this study, we investigated the nuclear factor-<b>κ</b>B (NF-κB)-regulated immune response against infection of a clinical strain Dkp23 and a live-attenuated Enterisol vaccine strain in PK-15 cells. …”

Western blots used for Fig 4C. by Huan W. Yang (19746645)

“…<i>intracellularis</i> infection. In this study, we investigated the nuclear factor-<b>κ</b>B (NF-κB)-regulated immune response against infection of a clinical strain Dkp23 and a live-attenuated Enterisol vaccine strain in PK-15 cells. …”

Centrifuged FMT products consistently exhibit the lowest median log₁₀ drop of CFU/g following freezing and lyophilization. In contrast, unprocessed feces exhibited the greatest median log₁₀ drop and had a statistically significant loss of bacterial viability across both storage conditions. Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing.... by Nina K. Randolph (21030732)

“…Products with M:D were the only cryopreserved products to exhibit a significant decrease in surrogate bacterial viability after freezing. …”

Magnification x2 of Fig 1B. by Huan W. Yang (19746645)

“…<i>intracellularis</i> infection. In this study, we investigated the nuclear factor-<b>κ</b>B (NF-κB)-regulated immune response against infection of a clinical strain Dkp23 and a live-attenuated Enterisol vaccine strain in PK-15 cells. …”

Cyclosporin A significantly reduces the survival rate and completely inhibits the formation of multicellular aggregates in tolerant strains under caspofungin stress. by Yongqin Wu (272012)

“…<p>(A) Cyclosporin A decreases the survival rate of tolerant strains under caspofungin. …”

Graphical representation of surface roughness values on the specimen surface after tests conducted at different time intervals (a) Ra, Rq (b) Rz (c) Sa, Sq (d) Sz, Sp, Sv. by Yang Li (7082)

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Discovery of Novel [1,2,4]Triazolo[1,5‑<i>a</i>]pyrimidine Derivatives as Novel Potent S‑Phase Kinase-Associated Protein 2 (SKP2) Inhibitors for the Treatment of Cancer by Kaizhao Hu (15670612)

“…Pharmacological inhibition of Skp2 has exhibited promising antitumor activity. Herein, we present the design and optimization of a series of [1,2,4]triazolo[1,5-<i>a</i>]pyrimidine-based small molecules targeting Skp2. …”

Volcano plot on differential expression. by Bingshuo Shi (21485387)

“…The findings revealed that 5558 genes in total were significantly altered during diapause, with pyruvate kinase (PK), trehalose synthase (TPS), superoxide dismutase (SOD), citrate synthase (CS), and 20-hydroxyecdysone (20E) showing significant decreases. …”

Dose-response curve of the activity of chitosan solution (A), blank chitosan-TPP nanoparticles (B), AmB loaded chitosan-TPP nanoparticles (C) and AmB solution (pure) (D) against L. by Alaa Riezk (7037297)

Organic solvent exposure causes defects in salt chemotaxis learning. by Masahiro Tomioka (430683)

Critical Role of Voltage Application Points in “Analog” and “Digital” Electrospray Ionization Mass Spectrometry by Min-Min Hung (21096009)

“…We also show that a single-polarity square AC waveform can be applied to the union or sample reservoir electrode, and if its frequency is sufficiently high, it has a similar effect as decreasing DC voltage, allowing for digital control of electrospray with square waves (by varying duty cycle). …”

Critical Role of Voltage Application Points in “Analog” and “Digital” Electrospray Ionization Mass Spectrometry by Min-Min Hung (21096009)

“…We also show that a single-polarity square AC waveform can be applied to the union or sample reservoir electrode, and if its frequency is sufficiently high, it has a similar effect as decreasing DC voltage, allowing for digital control of electrospray with square waves (by varying duty cycle). …”

Participant characteristics. by Ronald Kusolo (13200268)

“…Uganda conducted its first nationally representative NCD risk factor survey in 2014, and a second in 2023. We analyzed the prevalence of the common NCD risk factors to assess changes in these between 2014 and 2023. …”

Effects of clonal integration and <i>Bacillus subtilis</i> on ramet number (A, E, I), total stolon length (B, F, J), specific stolon length (C, G, K), and root-shoot ratio (D, H, L... by Bing-Nan Zhao (21553401)

Uganda 2023 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

“…Uganda conducted its first nationally representative NCD risk factor survey in 2014, and a second in 2023. We analyzed the prevalence of the common NCD risk factors to assess changes in these between 2014 and 2023. …”

Uganda 2014 NCD risk factor STEPS survey data. by Ronald Kusolo (13200268)

“…Uganda conducted its first nationally representative NCD risk factor survey in 2014, and a second in 2023. We analyzed the prevalence of the common NCD risk factors to assess changes in these between 2014 and 2023. …”